Supernus Pharmaceuticals, Inc.

Stephens Investment Management Group LLC SUPN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/5/2026

Shares

1,406,522

Value ($000)

69,904

Weight

0.9%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/5/2026	69,904	0.9%	1,406,522	12/31/2025
2025 Q3	10/28/2025	64,297	0.8%	1,345,402	9/30/2025
2025 Q2	7/30/2025	49,836	0.7%	1,581,093	6/30/2025
2025 Q1	5/1/2025	56,935	0.8%	1,738,482	3/31/2025
2024 Q4	1/28/2025	63,355	0.8%	1,752,068	12/31/2024
2024 Q3	10/28/2024	60,246	0.8%	1,932,209	9/30/2024
2024 Q2	8/6/2024	50,785	0.7%	1,898,499	6/30/2024
2024 Q1	5/14/2024	64,870	0.9%	1,901,776	3/31/2024
2023 Q4	2/13/2024	55,127	0.8%	1,904,864	12/31/2023
2023 Q3	11/14/2023	46,999	0.8%	1,704,698	9/30/2023
2023 Q2	8/15/2023	51,123	0.8%	1,700,715	6/30/2023
2023 Q1	5/15/2023	60,224	1.0%	1,662,262	3/31/2023
2022 Q4	2/14/2023	57,579	1.0%	1,604,769	12/31/2022
2022 Q3	11/7/2022	54,357	1.0%	1,605,806	9/30/2022
2022 Q2	8/3/2022	46,630	0.9%	1,612,382	6/30/2022
2022 Q1	5/4/2022	51,755	0.8%	1,601,344	3/31/2022
2021 Q4	2/15/2022	46,014	0.6%	1,577,980	12/31/2021
2021 Q3	10/27/2021	33,073	0.4%	1,240,078	9/30/2021
2021 Q2	8/9/2021	38,344	0.5%	1,245,329	6/30/2021
2021 Q1	5/14/2021	29,859	0.4%	1,140,519	3/31/2021
2020 Q4	2/10/2021	21,270	0.3%	845,378	12/31/2020
2020 Q3	11/13/2020	6,224	0.1%	298,640	9/30/2020
2020 Q2	8/24/2020	6,399	0.1%	269,422	6/30/2020
2020 Q1	5/14/2020	5,054	0.1%	280,947	3/31/2020
2019 Q4	2/14/2020	6,643	0.1%	280,053	12/31/2019